Can Indonesia Be a Biopharmaceutical Manufacturing Powerhouse?
5 – 7 NOVEMBER 2019
JL. PULOMAS BARAT KAVLING 88, EAST JAKARTA
The biopharmaceutical industries in Asia is rapidly growing and is expected to reach its highest growth by 2020. An increase in health care spending and adoption of biopharmaceuticals by physicians, pharmacies, drug wholesalers, and patients in the region contribute to the high growth rate of Asia’s biopharmaceutical industries. Moreover, various global pharmaceutical companies have formed partnerships with academic institutions and local biopharmaceutical companies in this region to establish innovation centers and manufacturing facilities to accelerate the development of this industry.
Although Indonesia is the largest pharmaceutical market in South East Asia, Indonesia’s biopharmaceutical industry is still in its emerging state. To accelerate and solidify the growth of the biopharmaceutical industry in Indonesia, i3L is organizing the first regional biopharmaceutical conference in Indonesia as a platform to facilitate networking and knowledge sharing among key stakeholders. Featuring an excellent lineup of local and international speakers across different specializations of the biopharmaceutical industry, this event is expected to generate invaluable insider knowledge into the biopharmaceutical markets in Indonesia and the region